Tissue repair & recovery research
Tri-Heal Max Protocol (Tri-Heal Max): Research Overview
Vendor blend of three repair-research peptides at high stated content. Untrialled as a blend.
Also known as Tri-Heal Max
What is Tri-Heal Max Protocol?
Tri-Heal Max is an enhanced healing peptide blend featuring a higher dose of TB-500 (25mg) combined with BPC-157 (10mg) and KPV (10mg) for a total of 45mg per vial. This formulation emphasizes TB-500's tissue repair and cellular migration properties, complemented by BPC-157's growth factor upregulation and KPV's anti-inflammatory effects.
What is Tri-Heal Max Protocol researched for?
- Higher TB-500 dose targets more severe tissue damage requiring enhanced repair.
- TB-500 promotes muscle fiber repair and cellular migration.
- Combined collagen support and growth factor upregulation.
- Multi-modal support for surgical wound recovery.
- KPV component reduces post-surgical inflammatory response.
- Enhanced tissue remodeling may reduce scar formation.
- Accelerated return to activity after sports injuries.
- Address accumulated tissue damage from repetitive stress.
How does Tri-Heal Max Protocol work?
Each peptide contributes distinct healing pathways: TB-500 (Thymosin Beta-4) enhances cellular migration, promotes actin polymerization, and supports blood vessel formation for tissue repair; BPC-157 upregulates growth factors (VEGF, EGF), accelerates wound healing, and provides gastrointestinal protection; KPV (alpha-MSH fragment) inhibits the NF-κB inflammatory pathway, reduces pro-inflammatory…
References
Thymosin Beta-4 (TB-500) Tissue Repair Multiple Studies TB-500 promotes cell migration, blood vessel formation, and wound healing through actin modulation.
TB-500 promotes cell migration, blood vessel formation, and wound healing through actin modulation.
BPC-157 Healing Properties Current Pharmaceutical Design BPC-157 upregulates growth factors and accelerates healing of various tissue types.
BPC-157 upregulates growth factors and accelerates healing of various tissue types.
KPV Anti-Inflammatory Effects Peptide Research KPV (alpha-MSH 11-13) inhibits NF-κB pathway and reduces pro-inflammatory cytokines.
KPV (alpha-MSH 11-13) inhibits NF-κB pathway and reduces pro-inflammatory cytokines.
No Published Studies on Tri-Heal Max Combination
2024
Specific three-peptide combination has not been studied in clinical trials.
Common questions
Is KPV necessary in Tri-Heal Max or is it just TB-500 and BPC-157?
KPV adds anti-inflammatory effects by inhibiting the NF-κB pathway and reducing pro-inflammatory cytokines, complementing TB-500's cell migration and BPC-157's growth factor upregulation. KPV may also reduce injection site reactions, making the three-peptide blend more tolerable than two-peptide combinations.